Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.38p
   
  • Change Today:
      0.43p
  • 52 Week High: 11.70p
  • 52 Week Low: 7.50p
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 1,583,845
  • Market Cap: £107.67m

Deal with Barclays    Trade now with Barclays Stockbrokers

Company Description

Scancell is a biopharmaceutical company focused on the cancer therapeutics market.

IPO Details

Issue Date 30-Jul-2010 Prospectus n/a
Issue Price n/a Lead Broker Zeus Capital
Market Cap £9.95m Contact Tel 0161 831 1512
Method Introduction    
Sector Pharmaceutical & Biotechnology    
Market Aim    
Amount Raised £0.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 10.38p
Change Today 0.43p
% Change 4.27 %
52 Week High 11.70p
52 Week Low 7.50p
Volume 1,583,845
Shares Issued 1,037.78m
Market Cap £107.67m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 08-Dec-2025

Time Volume / Share Price
12:59 8,049 @ 10.33p
12:46 58 @ 10.34p
11:46 138,979 @ 10.06p
12:35 8,725 @ 10.35p
12:29 18,472 @ 10.13p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page